Publication | Closed Access

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)

Placebo-controlled Phase 3Endovascular TechniqueVascular SurgeryNeurologyNeurovascular DiseaseEndothelin Receptor AntagonistMedicineAnesthesiology